Streetbeat News

Products Services

TSLA

A biopic about Elon Musk, based on a biography by Walter Isaacson, is being developed by A24 with Darren Aronofsky set to direct. The film will explore Musk's life, including his roles at Tesla Inc, SpaceX, and the acquisition of Twitter. No casting or release date details are available yet. The biopic's impact on Musk's past work, including the 'Steve Jobs' biopic, suggests potential interest in the upcoming film.

Portfolio Pulse from Chris Katje

November 10, 2023 | 3:27 pm

AMZN

GOOG

GOOGL

Amazon is developing its own operating system, Vega, to replace Android on its devices, aiming for a 2024 release. The OS will reduce reliance on Android Open Source Project and allow for a broader range of app development. Amazon's move is strategic to gain control over its technology and expand monetization opportunities. AMZN shares saw a slight increase of 0.48% to $141.37.

Portfolio Pulse from Anusuya Lahiri

November 10, 2023 | 2:51 pm

ALVO

STADA and Alvotech have received a positive CHMP opinion for Europe's first biosimilar to Stelara, Uzpruvo (AVT04), for use in gastroenterology, dermatology, and rheumatology. This marks the first EMA proposal for a biosimilar to Stelara, with potential market entry into the €2.5 billion EU ustekinumab market. STADA holds commercial rights in Europe, while Alvotech is responsible for development and manufacturing. The biosimilar could significantly expand patient access and provide cost-effective treatment options in the EU.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:30 pm

EAT

Brinker International (NYSE:EAT), owner of Chili's Grill & Bar, reported a 5.8% increase in comparable sales year-over-year for Q1, with revenue of $1.012 billion. Chili's, known for its margaritas, would rank as the third-largest buyer of tequila if it were a country. The company's focus on 'core four' items, including margaritas, is part of its strategy to return to the basics of casual dining. Brinker projects FY2024 revenue of $4.27 to $4.35 billion and EPS of $3.35 to $3.65.

Portfolio Pulse from Chris Katje

November 10, 2023 | 2:23 pm

AAPL

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSM) reported a significant month-on-month topline growth of 34.8% in October, with the strong dollar and Apple Inc's new product launch contributing to this growth. TSMC is also planning to build its second wafer fab in Japan, focusing on 6nm process manufacturing, with substantial financial commitment from the Japanese government. Nvidia Corp's CEO praised TSMC for its role in Nvidia's success at a recent event in Taipei.

Portfolio Pulse from Anusuya Lahiri

November 10, 2023 | 2:13 pm

EXEL

Exelixis, Inc. (NASDAQ:EXEL) announced initial results from an expansion cohort of STELLAR-001 evaluating zanzalintinib in patients with previously treated clear cell renal cell carcinoma (ccRCC). The results demonstrated an objective response rate of 38% and a disease control rate of 88%. The findings were presented at the 2023 International Kidney Cancer Symposium (IKCS). The results are encouraging for patients with advanced kidney cancer who have exhausted their treatment options.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:03 pm

COCH

Envoy Medical has announced the publication of an additional patent for its implantable cochlear systems. The patent, titled 'Implantable Cochlear System with Inner Ear Sensor', is part of Envoy's growing technology portfolio aimed at serving the under-penetrated hearing implant market.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:01 pm

CYTO

Altamira Therapeutics Ltd. (NASDAQ:CYTO) has received an 'Intention to Grant' notice from the European Patent Office for its patent application titled 'Intranasal Composition Comprising Betahistine'. The patent, expected to remain valid until February 2038, will provide key intellectual property protection for the company's intranasal betahistine program (AM-125) in Europe. The patent has been granted in around 50 countries worldwide, including key markets in North America and Europe.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:47 pm

FIGS

MOTS

TTD

Figs shares rose premarket due to investor Ron Baron discussing the stock on CNBC. The Trade Desk shares fell after issuing Q4 revenue guidance below estimates. Motus GI announced the first upper GI patient procedure for FDA cleared Pure-Vu® EVS Gastro, causing a significant rise in its shares.

Portfolio Pulse from ryanfaloona@benzinga.com

November 10, 2023 | 1:42 pm

MOTS

Motus GI announced that the Pure-Vu EVS Gastro was successfully used in the first procedure since receiving FDA clearance, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 1:40 pm